Myocardial Effects of Adrenaline, Isoprenaline and Dobutamine at Hypothermic Conditions
Authors:
Open Access
- 1 May 1990
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 66 (5) , 354-360
Abstract
The pharmacodynamic myocardial effects of adrenaline, isoprenaline and dobutamine were studied in isolated, perfused and spontaneously beating rabbit hearts at hypothermic conditions. Cardiac contraction amplitude increased from the control value at 37° set equal to 100% to about 165% at 22°, whereas contraction velocity decreased to 52%, frequency to 30% and oxygen consumption to about 19%. At 22° all drugs produced pronounced positive inotropic and chronotropic effects. Em‐values related to contraction velocity, frequency and oxygen consumption were for isoprenaline 152, 98 and 136%, respectively, for adrenaline 127, 100 and 198% and for dobutamine 120, 86 and 165%, respectively. The corresponding EC50‐values decreased and a marked left‐shift of the log‐concentration response curves was observed as an expression of increased myocardial sensitivity to the drugs. Em for contraction velocity for dobutamine was distinctly reduced at 32 and 27° and for adrenaline at 27° in comparison to the increase seen at 22 and 37°. Em for oxygen consumption showed for all drugs an increase at decreasing temperatures. The frequency‐corrected QTc‐interval decreased slightly to moderately during exposure to the drugs at hypothermic conditions. None of the drugs caused arrhytmias during the experiments. Coronary flow rate decreased only moderately at the higher drug concentrations at decreased temperatures. Dobutamine and adrenaline at 37° and isoprenaline at 37 and 22° caused an increase of Em for oxygen consumption that was slightly less than proportional to the increase of Em for contraction velocity.Keywords
This publication has 18 references indexed in Scilit:
- Inotropic response to hypothermia and the temperature-dependence of ryanodine action in isolated rabbit and rat ventricular muscle: implications for excitation-contraction coupling.Circulation Research, 1987
- Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarctionAmerican Heart Journal, 1985
- Temperature dependence of β1-adrenoceptor-mediated responses examined by use of partial agonistsEuropean Journal of Pharmacology, 1985
- A fundamental temperature-dependent difference between β-adrenoceptor agonists and antagonistsLife Sciences, 1984
- Cardiovascular Effects of a New Positive Inotropic Agent, (−)-(R)-1-(p-Hydroxyphenyl)-2-[(3,4-Dimethoxyphenethyl) Amino]-Ethanol (TA-064) in the Anesthetized Dog and Isolated Guinea Pig HeartThe Japanese Journal of Pharmacology, 1984
- The contribution of metabolism to the hypothermia-induced supersensitivity of guinea-pig isolated atria; selective supersensitivity for β-adrenoceptor agonists and their positive inotropic responsesGeneral Pharmacology: The Vascular System, 1977
- Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamineProgress in Cardiovascular Diseases, 1977
- Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.Circulation Research, 1975
- Diagnostic value of electrocardiographic abnormalities observed in subjects accidentally exposed to coldThe American Journal of Cardiology, 1972
- Negative inotropic responses of the isolated heart of the rat to isoprenalineBritish Journal of Pharmacology, 1972